June 2025 ITL FOCUS: Health By Insurance Thought Leadership ITL FOCUS is a monthly initiative featuring topics related to innovation in risk management and insurance.
Health Insurance Enters Uncharted Waters By Insurance Thought Leadership Developments in gene therapy and drugs hold remarkable promise, but how do insurers set premiums when there's no historical data for them?
Mortality Considerations for Underserved Markets By Ryan Shubert Mike Cusumano New mortality data reveals underserved insurance markets present unique risks beyond traditional underwriting solutions.
Telemedicine and Remote Monitoring By Theo Morrill A strategic opportunity: Insurance companies are leveraging telemedicine and remote monitoring to transform care delivery while reducing costs.
The Turing Test for Insurance By Sam Henry Can an AI imitate—and eventually outperform—a top licensed life insurance producer?
ERISA Lawsuits Surge Refocuses Risk Management By Richard Clarke ERISA lawsuits surge 183% in 2024, forcing plan sponsors to reevaluate fiduciary risk management strategies.
AI Document Processing Transforms Medical Reviews By Tycho Speekenbrink As a look at Medicare Set-Asides shows, AI can create huge efficiencies but also brings new risks.
9 Keys for Managing Genetic Testing Benefits By Bill Kerr Health plans need to incorporate these nine elements to effectively manage the rapid growth of genetic testing benefits.
Auto Insurance in an Existential Crisis By Stephen Applebaum Alan Demers The 125-year-old, $300 billion U.S. auto insurance industry is caught between runaway inflation and strained consumer wallets.
The Promise of Continuous Underwriting By Bill Deemer Bobby Touran Typically, a risk is underwritten, bound... and forgotten. But new streams of data and automation allow for continuous underwriting.
Convergence and the Insurance Ecosystem By Stephen Applebaum Alan Demers Companies must anticipate the future, innovate beyond their core and transform their capabilities as rapidly as technology allows.
Lemonade's 'Synthetic Agent' Nonsense By Matteo Carbone Desperate for growth, Lemonade produces another howler: A lender receiving a 16% interest rate is presented as a (synthetic) agent.